Op2Lysis develops innovative thrombolytic therapies, using NANOp2Lysis® technology and OptPA to dissolve brain hematomas and blood clots, aiming to treat stroke and intracerebral hemorrhage.
About
Join us
Become a BioWin member today and benefit from improved networking and industry intelligence in the life sciences and health sector.